• LAST PRICE
    5.3000
  • TODAY'S CHANGE (%)
    Trending Down-0.2800 (-5.0179%)
  • Bid / Lots
    5.2500/ 189
  • Ask / Lots
    5.6900/ 1
  • Open / Previous Close
    5.5600 / 5.5800
  • Day Range
    Low 5.2425
    High 5.6000
  • 52 Week Range
    Low 2.1300
    High 7.7300
  • Volume
    275,380
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.58
TimeVolumePBYI
09:38 ET33005.55
09:39 ET18005.49
09:41 ET16365.42
09:43 ET7995.47
09:45 ET6005.47
09:50 ET2065.46
09:52 ET2505.485
09:54 ET6005.5
09:57 ET9005.46
09:59 ET12965.42
10:01 ET3025.45
10:06 ET21755.47
10:08 ET3005.45
10:10 ET24995.42
10:12 ET1005.43
10:14 ET35165.4201
10:15 ET12005.435
10:17 ET1505.4338
10:19 ET12565.43
10:21 ET29035.42
10:24 ET1305.42
10:26 ET22905.4
10:30 ET70035.33
10:32 ET22005.3295
10:37 ET2005.335
10:39 ET16805.3699
10:42 ET1005.37
10:44 ET6005.355
10:46 ET1005.355
10:48 ET40005.355
10:50 ET19165.4
10:51 ET1005.4
10:53 ET6005.4
10:57 ET27005.401
11:00 ET1005.405
11:04 ET13005.4
11:06 ET11005.395
11:08 ET1005.4
11:09 ET80185.3925
11:11 ET27975.3925
11:13 ET10305.44
11:18 ET4005.45
11:20 ET2515.45
11:26 ET1005.45
11:31 ET16505.4501
11:36 ET11035.45
11:42 ET1005.43
11:45 ET38035.43
11:47 ET30005.44
11:51 ET1005.41
11:54 ET2295.438
11:56 ET1005.41
12:00 ET2005.42
12:02 ET8005.42
12:07 ET2065.4147
12:12 ET4005.392
12:16 ET4005.39
12:23 ET1005.3904
12:25 ET4005.3968
12:30 ET143845.42
12:36 ET2005.4
12:38 ET21395.38
12:39 ET5005.38
12:41 ET26665.39
12:43 ET12225.38
12:45 ET6005.38
12:48 ET19615.38
12:50 ET17005.36
12:52 ET12445.3429
12:56 ET1005.33
12:57 ET1005.33
12:59 ET55235.33
01:01 ET2005.32
01:03 ET18515.31
01:06 ET1005.3
01:08 ET4005.32
01:12 ET1005.31
01:15 ET5005.3
01:21 ET15005.28
01:24 ET5005.2701
01:26 ET1005.27
01:28 ET3005.29
01:30 ET7505.2922
01:32 ET19225.31
01:33 ET11005.32
01:35 ET6905.31
01:42 ET44705.28
01:44 ET13005.31
01:46 ET7525.31
01:50 ET1005.31
01:51 ET8005.3
01:53 ET1005.3
01:55 ET1005.3
01:57 ET2005.3
02:00 ET2005.3
02:02 ET12785.31
02:04 ET7255.3
02:06 ET8005.3
02:08 ET1005.3
02:09 ET1005.3
02:11 ET4005.32
02:15 ET11005.3
02:20 ET49775.29
02:22 ET10805.31
02:24 ET1005.3
02:26 ET1005.3
02:31 ET15005.3
02:33 ET4635.3
02:36 ET1005.3
02:38 ET11005.29
02:40 ET11005.26
02:42 ET1005.26
02:44 ET41635.29
02:45 ET1005.3
02:49 ET1005.3
02:51 ET5005.295
02:54 ET1005.295
02:58 ET32685.295
03:00 ET7205.301
03:02 ET5005.29
03:03 ET7005.29
03:05 ET91945.33
03:07 ET79935.315
03:12 ET2005.315
03:14 ET1005.31
03:18 ET2005.31
03:21 ET16595.29
03:23 ET4005.29
03:25 ET11005.29
03:30 ET29135.2701
03:32 ET8945.26
03:34 ET23595.27
03:36 ET8755.26
03:39 ET13005.25
03:41 ET2005.25
03:43 ET5115.25
03:45 ET1005.25
03:48 ET1005.2471
03:50 ET7955.25
03:52 ET4005.25
03:54 ET6075.25
03:56 ET57955.29
03:57 ET34385.29
03:59 ET120305.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPBYI
Puma Biotechnology Inc
255.5M
11.7x
---
United StatesCHRS
Coherus BioSciences Inc
269.4M
-0.9x
---
United StatesRVNC
Revance Therapeutics Inc
512.7M
-1.3x
---
United StatesVNDA
Vanda Pharmaceuticals Inc
236.5M
93.7x
-37.98%
United StatesVYGR
Voyager Therapeutics Inc
505.5M
3.1x
---
United StatesAKBA
Akebia Therapeutics Inc
383.2M
-6.6x
---
As of 2024-03-29

Company Information

Puma Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of products to enhance cancer care. The Company's lead product is NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4 It also engaged in the development and commercialization of, alisertib. Alisertib is a selective, small molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A. Its neratinib has clinical application in the treatment of several other cancers as well, including other tumor types that over-express or have a mutation in HER2 or epidermal growth factor receptor (EGFR), such as breast cancer, cervical cancer, lung cancer, or other solid tumors.

Contact Information

Headquarters
10880 Wilshire Blvd., Suite 2150LOS ANGELES, CA, United States 90024
Phone
424-248-6500
Fax
424-248-6501

Executives

Chairman of the Board, President, Chief Executive Officer, Secretary
Alan Auerbach
Chief Financial Officer
Maximo Nougues
Senior Vice President - Regulatory Affairs, Medical Writing and Project Management
Douglas Hunt
Chief Scientific Officer
Alvin Wong
Chief Commercial Officer
Jeff Ludwig

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$255.5M
Revenue (TTM)
$235.6M
Shares Outstanding
48.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.27
EPS
$0.45
Book Value
$1.12
P/E Ratio
11.7x
Price/Sales (TTM)
1.1
Price/Cash Flow (TTM)
7.7x
Operating Margin
13.85%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.